Cardiovascular disease remains a massive public health and economic burden in the United States, requiring renewed emphasis on prevention and guideline adherence.
Answers are grounded in this paper and cite their sources.
These early-2000s figures highlight enduring CVD burden; leaves open effects of subsequent therapies on mortality and costs.
Cardiovascular disease (CVD) is the leading cause of death and a major cause of disability worldwide. In the United States, CVD accounted for 34.4 percent of the 2.4 million deaths in 2003 and remain a major cause of health disparities and rising health care costs. In 2006, health care spending and lost productivity from CVD exceeded 400 billion dollars. The aging population, obesity epidemic, underuse of prevention strategies, and suboptimal control of risk factors could exacerbate the future CVD burden. Increased adherence to clinical and community-level guidelines and renewed emphasis on policy, environmental, and lifestyle changes will be crucial for its effective prevention and control.
No takes yet. Share an insight, caveat, or question.
Mensah et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: